ADMA - ADMA Biologics Inc logo

ADMA

ADMA Biologics Inc

ADMA Biologics develops and manufactures plasma-derived biologics for treating immune deficiencies and infectious diseases. Its product portfolio includes intravenous immune globulin therapies and a human polyclonal antibody for Hepatitis B, primarily targeting U.S. patients.

โš•๏ธ Healthcare NASDAQ Listed 2013 $ USD
$1,000 invested 10 years ago โ†’$1,450today

Score Overview

1 Year
Score
Net Growth14.99%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth0.41%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score8.5
Net Growth335.82%
Net Trend80%
Net Income Consistencyโ€”
Rev Growth6x
Rev TrendEvery year
Revenue Consistencyโ€”
10 Years
Score
Net Growth10x
Net Trend60%
Net Income Consistency
Rev Growth48x
Rev Trend90%
Revenue Consistency
All Time
Score
Net Growth12x
Net Trend46%
Net Income Consistency
Rev Growth166x
Rev Trend92%
Revenue Consistency

See the full market ranking โ†’

ADMA Biologics Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 42M to $ 510M and net income went from -$ 75M to $ 146M. Revenue increased in every one of those 5 years; net income in 4.

Between 2015 and 2025, revenue grew from $ 7M to $ 510M and net income went from -$ 17M to $ 146M. Revenue increased in 9 of those 10 years; net income in 6.

ADMA Biologics Inc currently holds a 5-year HDB Score of 8.5 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-13
$ 9.41โ€”
1 Year2025-08-13
$ 17.20-45.29%
5 Years2021-08-13
$ 1.496x
10 Years2016-08-12
$ 6.4944.99%
All Time2013-10-17
$ 8.5510.06%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 512M$ 168M$ 136M
2025$ 510M$ 146M$ 87M
2024$ 426M$ 197M$ 103M
2023$ 258M-$ 28M$ 51M
2022$ 154M-$ 65M$ 86M
2021$ 80M-$ 71M$ 51M
2020$ 42M-$ 75M$ 55M
2019$ 29M-$ 48M$ 26M
2018$ 16M-$ 65M$ 22M
2017$ 22M-$ 43M$ 43M
2016$ 10M-$ 19M$ 15M
2015$ 7M-$ 17M$ 16M
2014$ 5M-$ 16M$ 21M
IPO2013$ 3M-$ 15M$ 29M

Explore beyond ADMA

You're looking at ADMA Biologics Inc. Members apply the same fundamental framework across all 3,859 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies